Avita Medical Ltd. (OTC: AVMXY) develops and distributes regenerative products to treat a broad range of wounds, scars and skin defects. The company’s patented and proprietary collection and application technology provides innovative treatment solutions derived…
Avino Silver & Gold Mines Ltd. (NYSE: ASM) is a Vancouver-based mining and exploration firm. Founded in 1968, Avino’s mission is to create shareholder value through profitable organic growth at the historic Avino property near…
Aurinia Pharmaceuticals, Inc. (NASDAQ: AUPH) is a late-stage biopharmaceutical company focused on the development of the therapeutic immunomodulating drug candidate voclosporin for the treatment of lupus nephritis. The company leverages its team’s past clinical experience…
Atossa Genetics Inc. (NASDAQ: ATOS) is focused on improving breast health through the development of innovative laboratory services, medical devices and therapeutics. The company’s laboratory services are being developed by its subsidiary, The National Reference…
AsteriasBiotherapeutics, Inc. (NYSE: AST) is a biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry-leading platforms are based on its pluripotent stem cell and allogeneic dendritic cell technologies. Asterias is currently…
Ascent Solar Technologies, Inc. (NASDAQ: ASTI) is a developer of thin-film photovoltaic modules with substrate materials that are more flexible, versatile and rugged than traditional solar panels. By pioneering a technology that is recognized as…
Arno Therapeutics, Inc. (OTCQB: ARNI) is a clinical stage biopharmaceutical company developing innovative products for the treatment of cancer and other life threatening diseases. The company has exclusive worldwide rights to develop and market three…
Arch Therapeutics, Inc. (OTCQB: ARTH) is a medical device company developing a novel approach to stop bleeding and control leaking during surgery and trauma care. The company’s innovative self-assembling peptide technology platform has been shown…
ARCA biopharma, Inc. (NASDAQ: ABIO) is dedicated to the development of genetically-targeted therapies for cardiovascular diseases. The company’s lead product candidate, bucindolol, is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed to treat…
Apricus Biosciences, Inc. (NASDAQ: APRI) is a biopharmaceutical company advancing innovative medicines in urology and rheumatology. The company has initiated a phase IIb trial for fispemifene, a selective estrogen receptor modulator for the treatment of…
Aoxing Pharmaceutical Company, Inc. (NYSE: AXN) is a specialty pharmaceutical company operating in China. The company specializes in the research, development, manufacture and distribution of a variety of narcotics and pain-management products. Aoxing currently operates…
Amyris, Inc. (NASDAQ: AMRS) is an integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Through the application of its innovative bioscience solutions, the company is able to convert…
American Lorain Corporation (NYSE: ALN) is an international processed snack foods, convenience foods and frozen foods company based in Shandong Province, China. The company recently announced the launch of a new breakfast product line, the…
AmpliPhi Biosciences Corporation (OTCQB: APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics. The company’s product development programs target infections that are often resistant to existing antibiotic treatments.…
American DG Energy, Inc. (NYSE: ADGE) is a leading supplier of low-cost energy through the commercialization of its affordable distributed power generating systems. The company’s On-Site Utility™ energy solutions are available without any capital or…
Amarin Corporation (NASDAQ: AMRN) is a biopharmaceutical company focused on the commercialization and development of therapeutics designed to improve cardiovascular health. The company’s product development program leverages its extensive experience in lipid science and the…
AlliquaBioMedical, Inc. (NASDAQ: ALQA) is a leading provider of advanced wound care solutions. Through its sales and distribution network, the company provides a suite of technological products that enhance the wound care practitioner’s ability to…
Agile Therapeutics, Inc. (NASDAQ: AGRX) is a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products that provide women with greater convenience and facilitate compliance. The company’s lead…
Agenus Inc. (NASDAQ: AGEN) is an immunology company focused on the discovery and development of novel checkpoint modulators, vaccines and adjuvants to treat cancer and other diseases. Using its proprietary platforms Retrocyte Display™ and SECANT®,…
Aethlon Medical, Inc. (NASDAQ: AEMD) is a leading developer of affinity biofiltrationdevices to treat life-threatening diseases. The company’s lead therapeutic candidate, Aethlon Hemopurifier®, is a first-in-class device that targets the rapid elimination of infectious viruses…
AeternaZentaris, Inc. (NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in the development and commercialization of novel treatments in the fields of oncology, endocrinology and women’s health. The company’s product pipeline includes Macrilen™, which is…
Aemetis, Inc. (NASDAQ: AMTX) is an advanced renewable fuels and renewable chemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products. The company currently owns and operates a…
ADMA Biologics, Inc. (NASDAQ: ADMA) is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disorder (PIDD) and certain infectious diseases.…
Actinium Pharmaceuticals, Inc. (NYSE: ANTM) is a biopharmaceutical company focused on the development of cancer drugs. The company’s product candidates are based on its patented technology, which combines the cancer targeting precision of monoclonal antibodies…
Acme United Corporation (NYSE: ACU) is a worldwide supplier of innovative cutting, measuring and safety products to the school, home, office, hardware, sporting goods and industrial markets. The company sells its products under a collection…
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain. The company’s leading product candidate, Zalviso™, is designed for the…
Today before the opening bell, International Stem Cell Corp. announced that it has entered into the second phase of the existing Research Agreement with Rohto Pharmaceutical Co., Ltd. (“Rohto”), a global Japanese pharmaceutical company recognized…
Accurexa, Inc. (OTCQB: ACXA) is focused on the development and commercialization of novel neurological therapies. The company’s propriety BranchPoint device was invented to deliver therapeutics, such as stem cells or gene therapy vectors, through the…
Abeona Therapeutics, Inc. (NASDAQ: ABEO) develops and delivers gene therapy and plasma-based products for severe and life-threatening diseases. The company’s lead programs are ABO-101 and ABO-102, which are adeno-associated virus-based gene therapies for the treatment…
22nd Century Group, Inc. (NYSE MKT: XXII) is a plant biotechnology company focused on the development of technology that permits the management of nicotine levels in tobacco plants through genetic engineering and plant breeding. The…
Houston-based ENGlobal (NASDAQ:ENG) is a specialty engineering firm charting its path to become a preferred provider of innovative automation integration services and select EPCM (engineering, procurement and construction management) projects worldwide. The company is specifically…
Digital Power designs, develops, manufactures and sells high-grade customized and off-the-shelf power system solutions for the most demanding applications in the medical, military, telecom and industrial markets. In July, the company unveiled its newest family…
International Stem Cell (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, this morning announced that company board member and Chief Scientific Officer Ruslan Semechkin, PhD, will present at the…
How do you find and profit from the best stock trading opportunities each day? If your daily routine includes checking your stocks and scouring the web for high quality plays, then you’re not alone. In…
Erin Energy is an independent oil and gas exploration and production company focused on energy resources in sub-Saharan Africa. The company’s asset portfolio includes nine licenses across four countries covering an area of approximately 16,600…
Skyline Medical, Inc. (NASDAQ: SKLN, SKLNU) is a medical device company engaged in the production and commercialization of an innovative, environmentally-friendly tool targeted at improving the safety of one of the most dangerous jobs in…
Catalyst Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative therapies for people with rare debilitating diseases. The company’s lead product candidate, Firdapse®, recently completed a pivotal phase III clinical trial…
On the cusp of milestone TGA (Therapeutic Goods Administration) authorization in Australia to start clinical trials in its breakthrough Parkinson’s disease (PD) treatment using human parthenogenetic neural stem cells (hpNSCs), International Stem Cell Corp. (OTCQB:…
ENGlobal, a leading provider of automation and engineering services, announced this morning that it has added two key professionals to its management team in newly created positions. The decision to expand its leadership team was…
In recent weeks, ENGlobal Corporation (NASDAQ: ENG) has provided prospective shareholders with a glimpse into its considerable growth potential. Despite slumping energy prices, the company demonstrated its versatility in the second quarter of 2015 by…